These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 33038060)
1. Resistant starch slows the progression of CKD in the 5/6 nephrectomy mouse model. Karaduta O; Glazko G; Dvanajscak Z; Arthur J; Mackintosh S; Orr L; Rahmatallah Y; Yeruva L; Tackett A; Zybailov B Physiol Rep; 2020 Oct; 8(19):e14610. PubMed ID: 33038060 [TBL] [Abstract][Full Text] [Related]
2. Metaproteomics reveals potential mechanisms by which dietary resistant starch supplementation attenuates chronic kidney disease progression in rats. Zybailov BL; Glazko GV; Rahmatallah Y; Andreyev DS; McElroy T; Karaduta O; Byrum SD; Orr L; Tackett AJ; Mackintosh SG; Edmondson RD; Kieffer DA; Martin RJ; Adams SH; Vaziri ND; Arthur JM PLoS One; 2019; 14(1):e0199274. PubMed ID: 30699108 [TBL] [Abstract][Full Text] [Related]
3. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats. Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529 [TBL] [Abstract][Full Text] [Related]
4. Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats. Kieffer DA; Piccolo BD; Vaziri ND; Liu S; Lau WL; Khazaeli M; Nazertehrani S; Moore ME; Marco ML; Martin RJ; Adams SH Am J Physiol Renal Physiol; 2016 May; 310(9):F857-71. PubMed ID: 26841824 [TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease and the gut microbiome. Hobby GP; Karaduta O; Dusio GF; Singh M; Zybailov BL; Arthur JM Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1211-F1217. PubMed ID: 30864840 [TBL] [Abstract][Full Text] [Related]
6. Modulation of the Gut Microbiota by Resistant Starch as a Treatment of Chronic Kidney Diseases: Evidence of Efficacy and Mechanistic Insights. Snelson M; Kellow NJ; Coughlan MT Adv Nutr; 2019 Mar; 10(2):303-320. PubMed ID: 30668615 [TBL] [Abstract][Full Text] [Related]
7. Characterizing the gut microbiota in patients with chronic kidney disease. Hu X; Ouyang S; Xie Y; Gong Z; Du J Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215 [No Abstract] [Full Text] [Related]
8. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change. Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110 [TBL] [Abstract][Full Text] [Related]
9. Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease. Wang S; Lv D; Jiang S; Jiang J; Liang M; Hou F; Chen Y Clin Sci (Lond); 2019 Sep; 133(17):1857-1870. PubMed ID: 31467135 [TBL] [Abstract][Full Text] [Related]
10. Effects of Resistant Starch on Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Du X; Wu J; Gao C; Tan Q; Xu Y J Diabetes Res; 2022; 2022():1861009. PubMed ID: 35899018 [TBL] [Abstract][Full Text] [Related]
11. Dynamics of salivary markers of kidney functions in acute and chronic kidney diseases. Kovalčíková AG; Pavlov K; Lipták R; Hladová M; Renczés E; Boor P; Podracká Ľ; Šebeková K; Hodosy J; Tóthová Ľ; Celec P Sci Rep; 2020 Dec; 10(1):21260. PubMed ID: 33277585 [TBL] [Abstract][Full Text] [Related]
12. A randomized double-blind cross-over trial to study the effects of resistant starch prebiotic in chronic kidney disease (ReSPECKD). Shamloo M; Mollard R; Wang H; Kingra K; Tangri N; MacKay D Trials; 2022 Jan; 23(1):72. PubMed ID: 35073986 [TBL] [Abstract][Full Text] [Related]
13. Metabolic phenotypes and the gut microbiota in response to dietary resistant starch type 2 in normal-weight subjects: a randomized crossover trial. Zhang L; Ouyang Y; Li H; Shen L; Ni Y; Fang Q; Wu G; Qian L; Xiao Y; Zhang J; Yin P; Panagiotou G; Xu G; Ye J; Jia W Sci Rep; 2019 Mar; 9(1):4736. PubMed ID: 30894560 [TBL] [Abstract][Full Text] [Related]
14. Resistant starch supplementation attenuates inflammation in hemodialysis patients: a pilot study. de Paiva BR; Esgalhado M; Borges NA; Kemp JA; Alves G; Leite PEC; Macedo R; Cardozo LFMF; de Brito JS; Mafra D Int Urol Nephrol; 2020 Mar; 52(3):549-555. PubMed ID: 32008198 [TBL] [Abstract][Full Text] [Related]
15. l-Carnitine improves cognitive and renal functions in a rat model of chronic kidney disease. Abu Ahmad N; Armaly Z; Berman S; Jabour A; Aga-Mizrachi S; Mosenego-Ornan E; Avital A Physiol Behav; 2016 Oct; 164(Pt A):182-8. PubMed ID: 27241631 [TBL] [Abstract][Full Text] [Related]
16. Role of Nitric Oxide Pathway in Development and Progression of Chronic Kidney Disease in Rats Sensitive and Resistant to its Occurrence in an Experimental Model of 5/6 Nephrectomy. Saracyn M; Czarzasta K; Brytan M; Murawski P; Lewicki S; Ząbkowski T; Zdanowski R; Cudnoch-Jędrzejewska A; Kamiński GW; Wańkowicz Z Med Sci Monit; 2017 Oct; 23():4865-4873. PubMed ID: 29018182 [TBL] [Abstract][Full Text] [Related]
17. Integrated gut microbiota and fecal metabolomics reveal the renoprotective effect of Rehmanniae Radix Preparata and Corni Fructus on adenine-induced CKD rats. Zhang ZM; Yang L; Wan Y; Liu C; Jiang S; Shang EX; Duan JA J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1174():122728. PubMed ID: 33975272 [TBL] [Abstract][Full Text] [Related]
18. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin. Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839 [TBL] [Abstract][Full Text] [Related]
19. Dietary Changes Involving Bifidobacterium longum and Other Nutrients Delays Chronic Kidney Disease Progression. Iwashita Y; Ohya M; Yashiro M; Sonou T; Kawakami K; Nakashima Y; Yano T; Iwashita Y; Mima T; Negi S; Kubo K; Tomoda K; Odamaki T; Shigematsu T Am J Nephrol; 2018; 47(5):325-332. PubMed ID: 29779028 [TBL] [Abstract][Full Text] [Related]
20. Compositional and Functional Adaptations of Intestinal Microbiota and Related Metabolites in CKD Patients Receiving Dietary Protein Restriction. Wu IW; Lee CC; Hsu HJ; Sun CY; Chen YC; Yang KJ; Yang CW; Chung WH; Lai HC; Chang LC; Su SC Nutrients; 2020 Sep; 12(9):. PubMed ID: 32932711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]